William Blair Investment Management, LLC Aerie Pharmaceuticals Inc Transaction History

William Blair Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$5.64 - $9.8 $10.2 Million - $17.7 Million	-1,807,563 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $7.51 Million - $14.3 Million	-1,069,586 Reduced 37.18%	1,807,563 $12.7 Million
Q3 2021 Nov 10, 2021	BUY	$11.32 - $16.63 $7.82 Million - $11.5 Million	690,649 Added 31.59%	2,877,149 $32.8 Million
Q2 2021 Aug 12, 2021	BUY	$15.16 - $18.97 $8.32 Million - $10.4 Million	548,628 Added 33.5%	2,186,500 $35 Million
Q1 2021 May 13, 2021	BUY	$13.12 - $20.9 $1.65 Million - $2.63 Million	125,831 Added 8.32%	1,637,872 $29.3 Million
Q4 2020 Feb 09, 2021	BUY	$9.12 - $14.49 $842,314 - $1.34 Million	92,359 Added 6.51%	1,512,041 $20.4 Million
Q3 2020 Nov 06, 2020	BUY	$10.46 - $14.46 $477,132 - $659,592	45,615 Added 3.32%	1,419,682 $16.7 Million
Q2 2020 Aug 12, 2020	BUY	$12.0 - $16.13 $16.5 Million - $22.2 Million	1,374,067 New	1,374,067 $20.3 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on William Blair Investment Management, LLC with notifications on news.